Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0000905148-26-000675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | 2026-02-10 | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $34.62 | -7,607 | 228.1K | -3% | -$263.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | F | D | 7,607 | $34.62 | 228,102 | D | — | — |